Neuroenteric Cyst

Comprehensive Clinical Guide: Neuroenteric Cysts

1. Introduction and Clinical Overview

A neuroenteric cyst (also known as an enterogenous cyst or neurenteric cyst) is a rare, benign, congenital developmental lesion arising from remnants of the primitive gut. These cysts are typically lined with endodermal epithelium, which distinguishes them from other cystic lesions of the central nervous system (CNS). While they are classified as benign, their location within the spinal canal or intracranial space often leads to significant morbidity due to mass effect, compression of neural structures, and potential for rupture.

Neuroenteric cysts are most frequently located in the spinal cord, specifically the cervicothoracic region, occupying the ventral or ventrolateral intradural extramedullary space. Though rare, they represent a critical diagnostic consideration in patients presenting with progressive myelopathy or radiculopathy.

2. Etiology and Pathophysiology

The formation of a neuroenteric cyst is rooted in the early embryological development of the notochord and the endoderm.

The Embryological Mechanism

During the third week of gestation, the notochordal plate separates from the endoderm. If this separation is incomplete, a persistent connection—known as the neurenteric canal—can remain between the yolk sac and the amniotic cavity.
* Sequestration: Fragments of endodermal tissue may become trapped within the developing mesoderm during the closure of the neural tube.
* Differentiation: These sequestered cells continue to secrete mucin or fluid, resulting in the expansion of the cyst over time.

Histological Classification (Wilkins and Odom)

Neuroenteric cysts are classified based on their histological characteristics, which correlate with their secretory activity and risk of recurrence:
1. Type A: Simple cysts lined with a single layer of cuboidal or columnar epithelium, often with goblet cells.
2. Type B: Cysts containing glandular structures, resembling the gastrointestinal tract.
3. Type C: Cysts containing glial or ependymal tissue, often associated with more complex spinal dysraphism.

3. Clinical Staging and Presentation

Clinical manifestations are highly dependent on the cyst's location (intracranial vs. spinal) and its size relative to the spinal canal.

Spinal Presentation

Most patients present between the second and fourth decades of life. Symptoms are usually insidious in onset:
* Progressive Myelopathy: Gait disturbance, weakness, and sensory deficits.
* Radicular Pain: Localized pain often exacerbated by Valsalva maneuvers.
* Brown-Séquard Syndrome: In cases of lateral compression.
* Sphincter Dysfunction: Late-stage manifestation indicating severe cord compression.

Intracranial Presentation

These are less common and typically occur in the posterior fossa (prepontine or cerebellopontine angle).
* Cranial Nerve Palsies: Particularly CN V, VII, or VIII.
* Obstructive Hydrocephalus: If the cyst blocks cerebrospinal fluid (CSF) flow.
* Headaches and Nausea: Symptoms of increased intracranial pressure.

4. Diagnostic Workup and Imaging

Accurate diagnosis requires advanced neuroimaging, as the cyst's appearance can mimic other lesions.

Key Diagnostic Tests

1. Magnetic Resonance Imaging (MRI): The gold standard.
   • T1-weighted: Variable (hypointense to hyperintense depending on protein content).
   • T2-weighted: Typically hyperintense.
   • Contrast (Gadolinium): Usually no enhancement of the cyst wall, though peripheral enhancement may occur if there is inflammation.
2. Computed Tomography (CT): Useful for assessing associated bony abnormalities (e.g., Klippel-Feil syndrome, spina bifida, or hemivertebrae).
3. Cine-MRI: Used to evaluate CSF flow dynamics if the cyst is obstructing the subarachnoid space.

Differential Diagnosis

• Arachnoid Cysts: Usually follow CSF signal intensity exactly on all sequences.
• Dermoid/Epidermoid Cysts: Often show restricted diffusion on Diffusion-Weighted Imaging (DWI).
• Neurenteric Cyst: Characterized by lack of restricted diffusion and potential proteinaceous content.
• Syringomyelia: A fluid-filled cavity within the cord, not an extramedullary mass.

5. Management and Surgical Intervention

The primary treatment for symptomatic neuroenteric cysts is surgical excision.

Surgical Approach

• Laminectomy/Hemilaminectomy: To gain access to the intradural space.
• Microsurgical Resection: The goal is total excision of the cyst wall. However, if the wall is densely adherent to the spinal cord or critical nerve roots, subtotal resection is preferred to avoid permanent neurological deficit.
• Fenestration: An alternative for lesions where total removal poses a high risk of injury to the spinal cord.

Risks and Complications

• CSF Leak: The most common immediate postoperative complication.
• Aseptic Meningitis: Caused by the release of cyst contents (mucin) into the subarachnoid space.
• Neurological Deficit: Injury to the spinal cord or nerve roots during dissection.
• Recurrence: High risk if the epithelial lining is not entirely removed.

6. Long-Term Prognosis

The prognosis is generally favorable following gross total resection. Most patients experience significant improvement in neurological function, provided the myelopathy was not long-standing. Long-term follow-up with serial MRI is mandatory to monitor for recurrence, which can occur even years after initial surgery.

7. Massive FAQ Section

1. Is a neuroenteric cyst considered a tumor?
No, it is a congenital malformation or hamartomatous lesion, not a neoplasm. It does not possess malignant potential.

2. Can neuroenteric cysts disappear on their own?
Extremely rarely. Because they are lined with secretory epithelium, they tend to expand over time.

3. What is the most common age of diagnosis?
While congenital, they are most frequently diagnosed in young to middle-aged adults (20–40 years old) when the cyst finally reaches a size that causes compression.

4. Why do these cysts cause pain?
The pain is often due to the mass effect on the nerve roots (radiculopathy) or the irritation of the dura mater by the cyst itself.

5. Are there any genetic links?
Neuroenteric cysts are generally sporadic. They are not typically hereditary, though they are often associated with other congenital spinal dysraphisms.

6. How do I distinguish a neuroenteric cyst from an arachnoid cyst on MRI?
Arachnoid cysts have signal intensity identical to CSF on all sequences. Neuroenteric cysts often have higher protein content, making them hyperintense on T1-weighted images.

7. Is surgery always required?
For asymptomatic, small, stable cysts, conservative management with serial imaging may be considered. Symptomatic cysts require surgical intervention.

8. What is the risk of recurrence after surgery?
The recurrence rate is approximately 10–20% if only subtotal resection is achieved. Total resection carries a much lower risk.

9. Can these cysts be treated with radiation?
Radiation therapy is not indicated for benign neuroenteric cysts and may carry risks of secondary malignancy or spinal cord damage.

10. What is "aseptic meningitis" in the context of this cyst?
During surgery, if the cyst ruptures and releases its mucinous contents into the subarachnoid space, it can trigger an intense inflammatory response, leading to chemical or aseptic meningitis.

8. Summary Table: Clinical Snapshot

9. Clinical Conclusion

Neuroenteric cysts represent a diagnostic challenge due to their rarity and their ability to mimic more common spinal pathologies. A high index of suspicion is required when encountering a patient with progressive, unexplained myelopathy, especially when accompanied by congenital vertebral anomalies. With the advent of microsurgical techniques, the majority of these patients can achieve a full recovery, emphasizing the importance of early detection and specialized neurosurgical management.